LARIMAR THERAPEUTICS, INC.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $92.7M | $177.9M | $85.4M | $90.1M | $20.6M | $21.1M | $33.2M | $35.1M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $160.7M | $205.0M | $142.0M | $183.2M | $145.6M | $165.5M | $195.3M | $213.3M |
| Property, Plant & Equipment | $639.0K | $558.0K | $622.0K | $709.0K | $797.0K | $855.0K | $881.0K | $779.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $165.3M | $208.5M | $145.8M | $187.4M | $150.0M | $170.2M | $200.2M | $219.0M |
| Liabilities | ||||||||
| Accounts Payable | $7.6M | $8.6M | $5.2M | $11.1M | $4.2M | $2.3M | $2.4M | $1.7M |
| Total Current Liabilities | $34.2M | $47.8M | $64.8M | $45.1M | $26.6M | $22.1M | $24.4M | $16.3M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $37.9M | $50.5M | $67.8M | $48.3M | $30.1M | $25.9M | $28.4M | $20.6M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-497.2M | $-464.4M | $-434.8M | $-372.3M | $-324.6M | $-298.4M | $-269.2M | $-240.3M |
| Total Stockholders' Equity | $127.4M | $158.0M | $78.1M | $139.0M | $119.9M | $144.3M | $171.8M | $198.4M |